Mailis A, Plapler P, Ashby P, Shoichet R, Roe S
Pain Investigation Unit, Toronto Hospital, Ontario, Canada.
Pain. 1997 Mar;70(1):59-68. doi: 10.1016/s0304-3959(96)03301-5.
This study examined the effects of intravenous administration of sodium amytal (SA), a medium action barbiturate, on cutaneous limb temperatures and sympathetic skin responses (SSR) to electrical stimulation. Eight normal volunteers and 13 patients with musculoskeletal pain, somatoform pain disorders or nerve/root injury (with findings strictly limited to the distribution of the distribution of the involved nerve) were compared to 15 patients with Complex Regional Pain syndromes (one of whom had documented nerve injury). The Complex Regional Pain Syndromes (CRPS) patients were characterized by the presence of severe diffuse limb pain and extraterritorial sensory, sudomotor and vasomotor abnormalities (i.e., not confined to the site of injury or the distribution of the injured nerve). The CRPS patients were different from the normal controls and the non-CRPS patients in their tendency to warm significantly many of their limbs (not just the symptomatic ones). SSR were reduced or lost in a few limbs only in all three groups, irrespective of the increase or decrease of limb temperature and the side of symptoms. We argue that the enhanced thermogenic effect of SA in CRPS patients is due to generalized central changes of thermoregulatory control specifically in this group.
本研究考察了静脉注射中效巴比妥酸盐戊巴比妥钠(SA)对皮肤肢体温度以及对电刺激的交感神经皮肤反应(SSR)的影响。将8名正常志愿者、13名患有肌肉骨骼疼痛、躯体形式疼痛障碍或神经/神经根损伤(其症状严格局限于受累神经的分布区域)的患者与15名患有复杂性区域疼痛综合征的患者(其中1名有记录在案的神经损伤)进行了比较。复杂性区域疼痛综合征(CRPS)患者的特征为存在严重的弥漫性肢体疼痛以及域外感觉、出汗和血管舒缩异常(即不限于损伤部位或受损神经的分布区域)。CRPS患者与正常对照组和非CRPS患者的不同之处在于,他们许多肢体(不仅仅是有症状的肢体)有明显变暖的倾向。在所有三组中,仅少数肢体的SSR降低或消失,而与肢体温度的升高或降低以及症状侧无关。我们认为,SA在CRPS患者中增强的产热效应是由于该组中体温调节控制的全身性中枢变化所致。